Trends and outcomes by inpatient and outpatient infusion of axicabtagene ciloleucel (axi-cel) in the US for patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL).

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.7023
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends and outcomes by inpatient and outpatient infusion of axicabtagene ciloleucel (axi-cel) in the US for patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL).

Waleska S. Pérez, Saurabh Dahiya, Frederick Lundry Locke, Hil Hsu et al.
Journal of Clinical Oncology
CAR-T cell therapy research
article

Trends and outcomes by inpatient and outpatient infusion of axicabtagene ciloleucel (axi-cel) in the US for patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL).

Waleska S. Pérez, Saurabh Dahiya, Frederick Lundry Locke, Hil Hsu, Caron Alyce Jacobson, Dafna Bonneh‐Barkay, Michael Hemmer, Jennifer Holter‐Chakrabarty, John H. Baird, Michael Tees, Brian McClune, E Pizzi, Fateeha Furqan, Jenny Kim, Jiali Yan, Marcelo C. Pasquini, Yi Lin, Zhongyu Feng
article en

Abstract

No abstract available for this paper.
Journal of Clinical OncologyVol. 43(16_suppl)
City Of Hope National Medical Center (US), The University of Texas MD Anderson Cancer Center (US), Medical College of Wisconsin (US), University of Utah (US), Huntsman Cancer Institute (US), Moffitt Cancer Center (US), Sarah Cannon (US), Dana-Farber Cancer Institute (US), Mayo Clinic in Arizona (US), Colorado Blood Cancer Institute (US), University of Oklahoma Health Sciences Center (US), Stanford University (US)
Openalex Percentile: Top 81%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Trends and outcomes by inpatient and outpatient infusion of axicabtagene ciloleucel (axi-cel) in the US for patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL). — Waleska S. Pérez, Saurabh Dahiya, et al. · Journal of Clinical Oncology (2025) | TGRS Research Map | TGRS